Company Filing History:
Years Active: 2001-2009
Title: Tatsuya Fujimura: Innovator in Transgenic Mammal Research
Introduction
Tatsuya Fujimura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals. With a total of 3 patents, his work focuses on enhancing organ transplantation through innovative genetic modifications.
Latest Patents
Fujimura's latest patents include groundbreaking inventions aimed at addressing the challenges of xenotransplantation. One notable patent involves a nonhuman transgenic mammal that carries a transgene comprising regulatory genes capable of functioning in hyperacute rejection-occurring local cells. This invention also includes a gene encoding human N-acetylglucosaminyltransferase III (GnT-III) and a human complement inhibitor. The transgenic mammal effectively inhibits hyperacute rejection, making it suitable for organ transplantation.
Another significant patent is for transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55). This invention provides transgenic mammals that carry the gene for the human complement inhibitor and express it in their organs and tissues, particularly in endothelial cells. These mammals are valuable as laboratory animals in medical and pharmacological research and can serve as sources of organs and tissues for human medical treatment.
Career Highlights
Fujimura is associated with Nippon Meat Packers, Inc., where he continues to advance his research in transgenic technology. His work has garnered attention for its potential to revolutionize organ transplantation and improve outcomes for patients in need of transplants.
Collaborations
Fujimura collaborates with notable colleagues, including Hiroshi Murakami and Koji Toyomura. Their combined expertise contributes to the innovative research being conducted in the field of transgenic mammals.
Conclusion
Tatsuya Fujimura's contributions to the field of biotechnology through his patents on transgenic mammals highlight his role as a key innovator. His work not only addresses critical challenges in organ transplantation but also paves the way for future advancements in medical treatments.